Project Grant R25AI183304
Award Date
8/1/24
Completion Date
6/30/29
Dollars Obligated
$340K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Puerto Rico
Similar Awards
This Project Grant award of $402,731 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to increase the number of physician-scientists in pediatrics or obstetrics/gynecology who can apply microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The grant will support 4 resident physicians to complete one year of laboratory-based training in immunology or...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant valued at $718,758 to the Texas Biomedical Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is focused on evaluating the use of IL-21-IgFc fusion protein as a host-directed immunotherapy to improve immune reconstitution and reduce the risk of latent tuberculosis (TB) reactivation in Mycobacterium tuberculosis (MTB) and simian immunodeficiency virus (SIV)...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $812,603 Project Grant under CFDA 93.855 (Allergy and Infectious Diseases Research) to the University of Houston System. The grant, awarded on June 9, 2025, supports research to develop selective inhibitors of the calcium-dependent protein kinase 1 (CDPK1) enzyme as a potential treatment for cryptosporidiosis, a significant public health threat caused by Cryptosporidium parasites. The research aims to optimize CDPK1...
This Project Grant award in the amount of $337,719 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will fund the "Maryland Infection, Immunization, Intervention, and Impact (M4I) Training Program" at the University of Maryland, Baltimore (UMB), a prominent public research university and academic health center. The M4I program aims to inspire medical students to pursue...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $328,482 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Idaho State University (ISU) to create the "ISU Bridges to Research Careers" (BRC) program. The BRC program aims to develop a pathway for undergraduate students from underrepresented populations to pursue biomedical careers. Key elements include a mentoring program for freshmen, a bacteriophage discovery and...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $569,210 Project Grant to the University of Colorado Boulder. The five-year grant, effective February 1, 2025, supports research to structurally and functionally characterize three proteins responsible for antimicrobial resistance, screen for probes to define inhibitory strategies, and develop a platform to quantitatively test the impact of target...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $395,496 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Regents of the University of California, San Francisco (UCSF) effective August 23, 2024. The funding will support a research project titled "Metagenomic Surveillance of Pathogen and Antimicrobial Resistance Gene Transmission in Hospitalized Neonates." The project aims to leverage metagenomic next-generation sequencing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $466,725 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of South Carolina. The 5-year grant, effective June 1, 2025 through May 31, 2030, will enhance the utility of deer mice as an infectious disease model. Specifically, the funding will: (1) strengthen the breeding capacity of the university's Peromyscus Genetic Stock Center, (2) develop Peromyscus-specific...
This Project Grant award of $378,904 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund an innovative research education program titled "Developing Research Leaders in Global Infectious Diseases in Women." The program aims to address the knowledge gap in sex differences in global infectious diseases and train the next generation of clinical investigators in this field. The program has...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $142,599 to the University of Texas at San Antonio (UTSA) to recruit, train, and graduate a diverse group of doctoral students in the multidisciplinary areas of molecular microbiology and immunology. The program aims to provide interdisciplinary training across host-pathogen interactions, immunology, genomics, and...